首页 > 市场调查报告书 > 医疗设备

市场调查报告书

商品编码

1935262

人工胰臟装置系统（APDS）市场按技术、分销管道和地区划分

Artificial Pancreas Device System (APDS) Market, By Technology, By Distribution Channel, By Geography

出版日期: 2026年01月16日 | 出版商:

Coherent Market Insights | 英文 151 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2026 年人工胰臟设备系统市场规模预计为 4.876 亿美元，预计到 2033 年将达到 16.342 亿美元，2026 年至 2033 年的复合年增长率为 18.9%。

报告内容		报告详情
基准年：	2025	2026年市场规模：	4.876亿美元
历史数据时期：	2020年至2024年	预测期：	2026年至2033年
预测期（2026-2033年）复合年增长率：	18.90%	2033 年的预测值：	16.342亿美元

1型糖尿病患者每天需要多次注射胰岛素。研究和技术进步促成了易于使用的胰岛素输注系统的商业化，包括胰岛素笔、胰岛素帮浦、吸入式胰岛素和注射器。这些先进、易用的胰岛素输注系统的出现，使得传统的注射器注射方式逐渐被淘汰。

此外，这些系统允许患者自行注射胰岛素。人工胰臟系统能够自动侦测患者血液或血浆中的葡萄糖水平，并据此调整所需的胰岛素剂量。例如，Medtronic的MiniMed 670G就是一款穿戴式人工胰腺，它能够自动监测葡萄糖水平，并透过连接到该装置的胰岛素帮浦输注胰岛素。人工胰臟技术包括发送器、感测器和胰岛素帮浦。这使得对体内胰岛素水平的持续监测成为可能，从而更便于糖尿病的管理。

市场动态

预计在预测期内，对新型人工胰腺装置系统的持续研究和开发将支持人工胰腺装置系统（APDS）市场的成长。

例如，2019 年 5 月，Beta Bionics 和 Zealand Pharma 开始对 iLet 仿生胰腺系统进行家庭试验，该系统是一种双激素泵系统，旨在根据连续血糖监测仪 (CGM) 的血糖值读数自动施用胰岛素和升糖素（Zealand Pharma 开发的一种在液态高血糖製剂）下稳定的实验胰性高升糖素製剂）。

预计第 1 型糖尿病的高发生率将增加对新型监测系统的需求，这将推动人工胰臟装置系统 (APDS) 市场在预测期内成长。

例如，根据世界卫生组织（WHO）的数据，全球糖尿病患者人数从1980年的1.08亿增加到2014年的4.22亿。此外，根据美国疾病管制与预防中心（CDC）的数据，第1型糖尿病约占美国成年人所有确诊糖尿病病例的5%。

本次调查的主要特点

本报告对全球人工胰腺装置系统 (APDS) 市场进行了详细分析，并以 2025 年为基准年，给出了预测期 (2026-2033) 的市场规模和復合年增长率 (%)。
该报告还重点介绍了各个细分市场的潜在商机，并概述了该市场具有吸引力的投资提案矩阵。
该研究还提供了有关市场驱动因素、限制因素、机会、新产品发布或核准、区域前景以及主要企业采取的竞争策略的重要见解。
该研究根据以下参数对全球人工胰腺装置系统 (APDS) 市场的主要企业进行了分析：公司概况、财务业绩、产品系列、地理分布、分销策略、关键发展和策略以及未来计划。
本报告的研究结果将使企业负责人和经营团队能够就未来的产品发布、技术升级、市场扩张和行销策略做出明智的决策。
这份全球人工胰臟装置系统（APDS）市场报告的目标受众是该行业的各类相关人员，包括投资者、供应商、产品製造商、经销商、新参与企业和金融分析师。
相关人员可以透过各种策略矩阵轻鬆做出决策，这些矩阵用于分析全球人工胰臟设备系统 (APDS) 市场。

北美洲
- 我们
- 加拿大
欧洲
- 英国
- 德国
- 义大利
- 法国
- 西班牙
- 俄罗斯
- 其他欧洲
亚太地区
- 中国
- 印度
- 日本
- ASEAN
- 澳洲
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲国家
非洲
- 中非
- 南非
- 北非
中东
- GCC
- 以色列
- 其他中东国家

第七章竞争情势

热图分析
公司简介
- Medtronic Plc.
- Medtrum Technologies Inc.
- Tandem Diabetes Care, Inc.
- Johnson &Johnson
- Beta Bionics, Inc.
- Bigfoot Biomedical
- Insulet Corporation
- Pancreum, Inc.
- TypeZero Technologies, Inc.
- DreaMed Diabetes Ltd
- Inreda Diabetic BV

第八章各节

参考
调查方法

简介目录

Product Code: CMI79

Artificial Pancreas Device System Market is estimated to be valued at USD 487.60 Mn in 2026 and is expected to reach USD 1,634.2 Mn by 2033, growing at a compound annual growth rate (CAGR) of 18.9% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 487.60 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	18.90%	2033 Value Projection:	USD 1,634.2 Mn

Type 1 diabetes patients require multiple doses of insulin in a day. Advancements in research and technology has led to commercialization of easy-to-use insulin delivery systems such as insulin pens, pumps, inhaled insulin, and injectors. Use of syringes to deliver insulin has become obsolete with the introduction of advanced and easy-to-use insulin delivery systems.

Moreover, these systems offer self-administration of insulin. Artificial pancreas system automatically detects glucose level in patient's blood or plasma, and accordingly administers necessary dosage of insulin. For instance, Medtronic's MiniMed 670G is one such wearable artificial pancreas that automatically monitors glucose levels, and delivers insulin through an insulin pump attached to the device. The artificial pancreas technology includes a transmitter, sensor, and insulin pump. This helps in continuous monitoring of insulin levels in body and manages diabetes at ease.

Market Dynamics

Continuous research and development of novel artificial pancreas device systems is expected to support the artificial pancreas device system (APDS) market growth over the forecast period.

For instance, in May 2019, Beta Bionics, Inc. and Zealand Pharma started an in-home trial of iLet Bionic Pancreas system, a dual-hormone pump system designed to automatically deliver insulin and dasiglucagon - an experimental form of glucagon designed by Zealand Pharma to be stable in liquid form- based on blood sugar readings from a continuous glucose monitor (CGM).

High prevalence of diabetes type 1 is expected to rise demand for its novel monitoring systems and drive the artificial pancreas device system (APDS) market growth over the forecast period.

For instance, according to the World Health Organization (WHO), number of diabetes patients worldwide increased from 108 million in 1980 to 422 million in 2014. Furthermore, according to the Center for Disease Control and Prevention (CDC), type 1 diabetes accounts for around 5% of the total diagnosed diabetes cases in adults in the U.S.

Key features of the study

This report provides in-depth analysis of global artificial pancreas device system (APDS) market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2026 - 2033), considering 2025, as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global artificial pancreas device system (APDS) market based on following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
Key companies covered as a part of this study include Medtronic Plc., Medtrum Technologies Inc., Tandem Diabetes Care, Inc., Johnson & Johnson, Beta Bionics, Inc., Bigfoot Biomedical, Insulet Corporation, Pancreum, Inc., TypeZero Technologies, Inc., DreaMed Diabetes Ltd, and Inreda Diabetic BV
Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future product launches, technology up-gradation, market expansion, and marketing tactics
The global artificial pancreas device system (APDS) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the global artificial pancreas device system (APDS) market

Market Segmentation

By Technology
- Threshold Suspended Device Systems
- Treat to Range/Control to Range (TTR/CTR)
- Treat to Target/ Control to Target (TTR/CTT)
By Distribution Channel
- Hospitals & Clinics
- Retail Channel
- Online Channel
By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East & Africa
- GCC Countries
- Israel
- Rest of Middle East & Africa
Artificial Pancreas Device System Market Companies
- Medtronic Plc.
- Medtrum Technologies Inc.
- Tandem Diabetes Care, Inc.
- Johnson & Johnson
- Beta Bionics, Inc.
- Bigfoot Biomedical
- Insulet Corporation
- Pancreum, Inc.
- TypeZero Technologies, Inc.
- DreaMed Diabetes Ltd
- Inreda Diabetic BV

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Technology
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Restraints
Market Opportunities
Impact Analysis
Technology Assessment
Reimbursement
Regulatory Scenario
Product Launch/Approval
Merger and Acquisitions/Collaborations
Product Pipeline Analysis
Pricing Analysis
PEST Analysis

4. Global Artificial Pancreas Device System (APDS) Market, By Technology, 2026 - 2033 (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026-2033
- Segment Trends
Threshold Suspended Device Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Treat to Range/Control to Range (TTR/CTR)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Treat to Target/ Control to Target (TTR/CTT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

5. Global Artificial Pancreas Device System (APDS) Market, By Distribution Channel, 2026 - 2033 (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026-2033
- Segment Trends
Hospitals & Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Retail Channel
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Online Channel
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

6. Global Artificial Pancreas Device System (APDS) Market, By Region, 2026 - 2033 (USD Mn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2026-2033
North America
- Market Size and Forecast, By Technology, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033 (USD Mn)
  - U.S.
  - Canada
Europe
- Market Size and Forecast, By Technology, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033 (USD Mn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Market Size and Forecast, By Technology, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033 (USD Mn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Latin America
- Market Size and Forecast, By Technology, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033 (USD Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Africa
- Market Size and Forecast, By Technology, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Country/Region, 2026 - 2033 (USD Mn)
  - Central Africa
  - South Africa
  - North Africa
Middle East
- Market Size and Forecast, By Technology, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033 (USD Mn)
  - GCC
  - Israel
  - Rest of Middle East

7. Competitive Landscape

Heat Map Analysis
Company Profiles
- Medtronic Plc.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Medtrum Technologies Inc.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Tandem Diabetes Care, Inc.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Johnson & Johnson
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Beta Bionics, Inc.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Bigfoot Biomedical
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Insulet Corporation
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Pancreum, Inc.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- TypeZero Technologies, Inc.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- DreaMed Diabetes Ltd
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Inreda Diabetic BV
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies

8. Section

References
Research Methodology
About us and Sales Contact

02-2729-4219

+886-2-2729-4219

License/价格

人工胰臟装置系统（APDS）市场按技术、分销管道和地区划分

Artificial Pancreas Device System (APDS) Market, By Technology, By Distribution Channel, By Geography

市场动态